Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancers (Q34777067)

4 August 2017

Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancers (English)

1 reference

4 August 2017

1 reference

Alessandra Tessitore

1

1 reference

4 August 2017

Francesca Zazzeroni

series ordinal

2

1 reference

4 August 2017

Edoardo Alesse

series ordinal

3

1 reference

4 August 2017

1 June 2013

1 reference

Expert Review of Proteomics

4 August 2017

1 reference

4 August 2017

10

1 reference

4 August 2017

3

1 reference

4 August 2017

223-226

1 reference

Comprehensive molecular portraits of human breast tumours

4 August 2017

1 reference

Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland

21 January 2018

1 reference

Adjuvant trastuzumab in HER2-positive breast cancer

21 January 2018

1 reference

Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy

21 January 2018

1 reference

How do you tell whether a breast cancer is HER2 positive? Ongoing studies keep debate in high gear.

21 January 2018

1 reference

Reverse phase protein microarrays advance to use in clinical trials

21 January 2018

1 reference

New therapies in HER2-positive breast cancer: a major step towards a cure of the disease?

21 January 2018

1 reference

Cancer stem cell hypothesis and trastuzumab in HER2-negative tumors.

21 January 2018

1 reference

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

21 January 2018

1 reference

Determining duration of HER2-targeted therapy using stem cell extinction models.

21 January 2018

1 reference

Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis

21 January 2018

1 reference

Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs

21 January 2018

1 reference

Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EPR.13.18

1 reference

release_led3b2mr6nhtzhzc44jswn4f5i

4 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/led3b2mr6nhtzhzc44jswn4f5i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference